UNBELIEVABLE: 3 - The Untold Story

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

International Business Times UK · Jul 27

Restricted eating hours may reduce cognitive decline in older age, researchers find

Preliminary study shows older people who avoided food four hours before bed did better in problem solving tests

The Guardian - UK · Jul 26

Millions of people are losing weight using GLP-1s. How do the drugs affect their love lives?

Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood

The Guardian - AU · Jul 25

Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year

After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body weight while also showing improvements in several cardiometabolic risk factors.

International Business Times · Jul 23

Weight loss drugs linked to loss of hair in major new study

The study looked at 50,000 people on GLP-1 agonist drugs such as Wegovy and Mounjaro

The Independent UK · Jul 22

Dietitians and Sleep Doctors Say TikTok's "Early Bird Dinner" Trend Is Actually Backed by Science

TikTok's early bird dinner trend has real science behind it. Sleep specialists and dietitians explain what eating earlier does to your body and who should be cautious.

Medical Daily · Jul 22

Target ultra-processed food to reduce obesity in Britain

Letter: James Capon responds to an editorial on the health select committee’s call for radical action to regulate food markets

The Guardian - UK · Jul 22

GLP-1 Drugs Like Ozempic Carry Elevated Risks of Muscle Loss and Malnutrition in Adults Over 65

GLP-1 drugs carry higher muscle loss, malnutrition, and bone density risks in adults over 65 that younger users don't face. Here's what older patients and prescribers need to know.

Medical Daily · Jul 21

A change in tradition

According to the Thai Health Promotion Foundation (Thai Health), monks are at 78% risk of developing non-communicable diseases, with the key factor being that food offered to them during alms-giving is often excessively sweet, fatty or salty.

Bangkok Post · Jul 20

A Record 40 Million Americans Are Now Taking GLP-1 Weight-Loss Drugs as Medicare Coverage Begins

A Gallup survey shows 11% of Americans now take GLP-1 drugs for weight loss as Medicare begins covering them for $50 monthly. Here's what it means for you.

Medical Daily · Jul 15